Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of National Health Investors Inc (NHI) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of National Health Investors Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 877860.
Total stock buying since 2015: $5,106,654.
Total stock sales since 2015: $4,162,004.
Total stock option exercises since 2015: $177,397,123.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 0 | $0 | 68,000 | $4,080,100 |
2024 | 10,437 | $615,648 | 0 | $0 | 719,966 | $42,166,911 |
2023 | 1,000 | $51,398 | 0 | $0 | 0 | $0 |
2022 | 2,500 | $155,495 | 0 | $0 | 18,333 | $979,165 |
2021 | 20,652 | $1,167,897 | 0 | $0 | 20,000 | $1,210,400 |
2020 | 41,047 | $1,784,381 | 7,043 | $637,915 | 346,001 | $25,208,134 |
2019 | 0 | $0 | 4,081 | $331,372 | 361,666 | $25,635,302 |
2018 | 3,097 | $204,442 | 12,778 | $1,025,297 | 302,500 | $20,098,262 |
2017 | 522 | $41,277 | 2,000 | $159,600 | 110,832 | $6,965,458 |
2016 | 0 | $0 | 22,702 | $1,589,785 | 444,998 | $28,605,923 |
2015 | 18,538 | $1,086,116 | 5,950 | $418,035 | 375,002 | $22,447,468 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-09 | 0 | $0 | 0 | $0 | 23,000 | $1,591,600 |
2025-03 | 0 | $0 | 0 | $0 | 45,000 | $2,488,500 |
2024-09 | 0 | $0 | 0 | $0 | 364,166 | $21,148,234 |
2024-08 | 0 | $0 | 0 | $0 | 310,800 | $18,530,177 |
2024-07 | 0 | $0 | 0 | $0 | 45,000 | $2,488,500 |
2024-05 | 437 | $28,768 | 0 | $0 | 0 | $0 |
2024-02 | 10,000 | $586,880 | 0 | $0 | 0 | $0 |
2023-08 | 1,000 | $51,398 | 0 | $0 | 0 | $0 |
2022-12 | 1,000 | $56,600 | 0 | $0 | 0 | $0 |
2022-08 | 1,500 | $98,895 | 0 | $0 | 18,333 | $979,165 |
2021-12 | 8,000 | $446,700 | 0 | $0 | 0 | $0 |
2021-11 | 1,000 | $52,860 | 0 | $0 | 0 | $0 |
2021-09 | 10,468 | $591,377 | 0 | $0 | 0 | $0 |
2021-06 | 1,184 | $76,960 | 0 | $0 | 0 | $0 |
2021-02 | 0 | $0 | 0 | $0 | 20,000 | $1,210,400 |
2020-12 | 2,000 | $135,500 | 0 | $0 | 0 | $0 |
2020-11 | 5,000 | $331,770 | 0 | $0 | 0 | $0 |
2020-05 | 425 | $20,553 | 0 | $0 | 0 | $0 |
2020-03 | 33,622 | $1,296,558 | 0 | $0 | 0 | $0 |
2020-02 | 0 | $0 | 7,043 | $637,915 | 346,001 | $25,208,134 |
2019-10 | 0 | $0 | 0 | $0 | 16,668 | $1,246,433 |
2019-09 | 0 | $0 | 900 | $74,911 | 0 | $0 |
2019-08 | 0 | $0 | 2,000 | $164,293 | 0 | $0 |
2019-07 | 0 | $0 | 0 | $0 | 16,666 | $1,072,123 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-09-23 | Travis David L (SVP/Chief Accounting Officer) | Option Ex | 23,000 | 69.20 | 1,591,600 |
2025-03-28 | Adams Robert G (Director) | Option Ex | 45,000 | 55.30 | 2,488,500 |
2024-09-25 | Gaines Kristin Sallee (SVP/Chief Transaction Officer) | Option Ex | 55,000 | 69.20 | 3,806,000 |
2024-09-18 | Travis David L (SVP/Chief Accounting Officer) | Option Ex | 12,000 | 69.20 | 830,400 |
2024-09-05 | Mendelsohn D. Eric (CEO and President) | Option Ex | 164,999 | 54.58 | 9,004,820 |
2024-09-03 | Spaid John L (CFO/EVP Finance) | Option Ex | 62,167 | 54.58 | 3,392,764 |
2024-09-03 | Webb Robert T (Director) | Option Ex | 70,000 | 58.77 | 4,114,250 |
2024-08-23 | Travis David L (SVP/Chief Accounting Officer) | Option Ex | 30,300 | 53.59 | 1,623,625 |
2024-08-23 | Spaid John L (CFO/EVP Finance) | Option Ex | 73,333 | 65.25 | 4,785,198 |
2024-08-23 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 117,167 | 60.20 | 7,054,039 |
2024-08-23 | Jobe James R (Director) | Option Ex | 45,000 | 55.30 | 2,488,500 |
2024-08-16 | Colden Tracy M J (Director) | Option Ex | 45,000 | 57.31 | 2,578,815 |
2024-07-29 | Mccabe Robert A Jr (Director) | Option Ex | 45,000 | 55.30 | 2,488,500 |
2024-05-31 | Mccabe Robert A Jr (Director) | Buy | 437 | 65.83 | 28,768 |
2024-02-27 | Swafford Charlotte A (Director) | Buy | 10,000 | 58.69 | 586,880 |
2023-08-30 | Jobe James R (Director) | Buy | 1,000 | 51.40 | 51,398 |
2022-12-14 | Adams Robert G (Director) | Buy | 1,000 | 56.60 | 56,600 |
2022-08-26 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 18,333 | 53.41 | 979,165 |
2022-08-15 | Adams Robert G (Director) | Buy | 1,500 | 65.93 | 98,895 |
2021-12-30 | Adams Robert G (Director) | Buy | 4,000 | 57.25 | 229,000 |
2021-12-01 | Webb Robert T (Director) | Buy | 2,000 | 51.60 | 103,200 |
2021-11-29 | Webb Robert T (Director) | Buy | 1,000 | 52.86 | 52,860 |
2021-09-30 | Webb Robert T (Director) | Buy | 2,000 | 53.86 | 107,716 |
2021-09-29 | Mendelsohn D. Eric (CEO and President) | Buy | 2,000 | 54.39 | 108,784 |
2021-09-17 | Webb Robert T (Director) | Buy | 1,500 | 57.25 | 85,875 |
2021-09-16 | Webb Robert T (Director) | Buy | 1,500 | 57.50 | 86,250 |
2021-09-14 | Webb Robert T (Director) | Buy | 1,500 | 58.00 | 87,000 |
2021-09-10 | Webb Robert T (Director) | Buy | 1,500 | 58.50 | 87,750 |
2021-09-09 | Mccabe Robert A Jr (Director) | Buy | 468 | 59.84 | 28,002 |
2021-06-17 | Webb Robert T (Director) | Buy | 1,184 | 65.00 | 76,960 |
2021-02-22 | Adams W Andrew (Director) | Option Ex | 20,000 | 60.52 | 1,210,400 |
2020-12-14 | Adams Robert G (Director) | Buy | 2,000 | 67.75 | 135,500 |
2020-11-18 | Adams Robert G (Director) | Buy | 4,000 | 66.33 | 265,320 |
2020-11-17 | Adams Robert G (Director) | Buy | 1,000 | 66.45 | 66,450 |
2020-05-13 | Adams Robert G | Buy | 425 | 48.36 | 20,553 |
2020-03-23 | Adams W Andrew (Director) | Buy | 27,000 | 36.16 | 976,319 |
2020-03-17 | Webb Robert T (Director) | Buy | 2,471 | 40.52 | 100,137 |
2020-03-16 | Webb Robert T (Director) | Buy | 2,151 | 46.28 | 99,552 |
2020-03-12 | Mendelsohn D. Eric (CEO and President) | Buy | 2,000 | 60.27 | 120,550 |
2020-02-24 | Reel Ronald V (Chief Accounting Officer) | Option Ex | 23,334 | 72.14 | 1,683,431 |
2020-02-24 | Pascoe Kevin Carlton (Chief Investment Officer) | Sale | 3,043 | 90.56 | 275,583 |
2020-02-24 | Mendelsohn D. Eric (CEO and President) | Sale | 4,000 | 90.58 | 362,332 |
2020-02-21 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 18,333 | 79.96 | 1,465,906 |
2020-02-20 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 16,668 | 64.33 | 1,072,252 |
2020-02-20 | Mendelsohn D. Eric (CEO and President) | Option Ex | 83,334 | 72.14 | 6,012,131 |
2020-02-17 | Adams W Andrew (Director) | Option Ex | 20,000 | 72.11 | 1,442,200 |
2020-02-14 | Mccabe Robert A Jr (Director) | Option Ex | 25,000 | 79.96 | 1,998,999 |
2020-02-13 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 18,333 | 79.96 | 1,465,906 |
2020-02-13 | Mendelsohn D. Eric (CEO and President) | Option Ex | 75,000 | 69.56 | 5,216,625 |
2020-02-11 | Spaid John L (CFO/EVP Finance) | Option Ex | 40,999 | 69.56 | 2,851,685 |
2020-02-07 | Jobe James R (Director) | Option Ex | 25,000 | 79.96 | 1,998,999 |
2019-10-23 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 16,668 | 74.78 | 1,246,433 |
2019-09-24 | Jobe James R (Director) | Sale | 900 | 83.23 | 74,911 |
2019-08-14 | Pascoe Kevin Carlton (Chief Investment Officer) | Sale | 1,100 | 81.89 | 90,079 |
2019-08-13 | Pascoe Kevin Carlton (Chief Investment Officer) | Sale | 900 | 82.46 | 74,214 |
2019-07-11 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 16,666 | 64.33 | 1,072,123 |
2019-02-21 | Mccabe Robert A Jr (Director) | Sale | 1,181 | 78.04 | 92,168 |
2019-02-01 | Hopkins Roger R (Chief Accounting Officer) | Option Ex | 50,000 | 73.89 | 3,694,500 |
2019-01-31 | Gaines Kristin Sallee (Chief Credit Officer) | Option Ex | 50,000 | 66.54 | 3,327,150 |
2019-01-31 | Mendelsohn D. Eric (CEO and President) | Option Ex | 80,000 | 73.89 | 5,911,200 |
2019-01-30 | Spaid John L (Exec. VP of Finance) | Option Ex | 40,000 | 67.35 | 2,693,880 |
2019-01-30 | Mccabe Robert A Jr (Director) | Option Ex | 20,000 | 74.78 | 1,495,600 |
2019-01-29 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 33,332 | 74.78 | 2,492,566 |
2019-01-29 | Webb Robert T (Director) | Option Ex | 40,000 | 69.56 | 2,782,200 |
2019-01-29 | Adams W Andrew (Director) | Option Ex | 15,000 | 61.31 | 919,650 |
2018-12-14 | Pascoe Kevin Carlton (Chief Investment Officer) | Sale | 2,070 | 79.60 | 164,772 |
2018-12-13 | Gaines Kristin Sallee (Chief Credit Officer) | Sale | 5,233 | 79.78 | 417,488 |
2018-12-12 | Gaines Kristin Sallee (Chief Credit Officer) | Sale | 5,475 | 80.92 | 443,037 |
2018-12-10 | Gaines Kristin Sallee (Chief Credit Officer) | Option Ex | 66,666 | 69.21 | 4,614,087 |
2018-12-07 | Mendelsohn D. Eric (CEO and President) | Option Ex | 41,666 | 64.33 | 2,680,373 |
2018-12-07 | Hopkins Roger R (Chief Accounting Officer) | Option Ex | 50,000 | 61.79 | 3,089,500 |
2018-08-07 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 16,666 | 64.33 | 1,072,123 |
2018-08-07 | Gaines Kristin Sallee (Chief Credit Officer) | Option Ex | 33,334 | 61.31 | 2,043,707 |
2018-08-07 | Jobe James R (Director) | Option Ex | 20,000 | 64.33 | 1,286,600 |
2018-07-06 | Mccabe Robert A Jr (Director) | Option Ex | 20,000 | 76.05 | 1,521,000 |
2018-06-07 | Mendelsohn D. Eric (CEO and President) | Option Ex | 37,500 | 74.19 | 2,782,125 |
2018-06-04 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 16,668 | 60.52 | 1,008,747 |
2018-05-25 | Mccabe Robert A Jr (Director) | Buy | 285 | 72.00 | 20,520 |
2018-02-26 | Mccabe Robert A Jr (Director) | Buy | 312 | 65.69 | 20,495 |
2018-02-22 | Spaid John L (Exec. VP of Finance) | Buy | 500 | 64.95 | 32,475 |
2018-02-22 | Mendelsohn D. Eric (CEO and President) | Buy | 2,000 | 65.48 | 130,952 |
2017-11-29 | Mccabe Robert A Jr (Director) | Buy | 263 | 78.23 | 20,573 |
2017-08-31 | Gaines Kristin Sallee (Chief Credit Officer) | Option Ex | 33,332 | 60.91 | 2,030,418 |
2017-08-28 | Mccabe Robert A Jr (Director) | Buy | 259 | 79.94 | 20,704 |
2017-08-24 | Pascoe Kevin Carlton (Chief Investment Officer) | Sale | 2,000 | 79.80 | 159,600 |
2017-07-03 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 13,334 | 72.11 | 961,514 |
2017-07-03 | Jobe James R (Director) | Option Ex | 20,000 | 74.78 | 1,495,600 |
2017-04-20 | Pascoe Kevin Carlton (Chief Investment Officer) | Option Ex | 16,666 | 60.52 | 1,008,626 |
2017-04-20 | Mendelsohn D. Eric (CEO and President) | Option Ex | 12,500 | 60.52 | 756,500 |
2017-02-17 | Adams W Andrew (Director) | Option Ex | 15,000 | 47.52 | 712,800 |
2016-08-30 | Mccabe Robert A Jr (Director) | Sale | 800 | 80.29 | 64,232 |
2016-08-23 | Hopkins Roger R (Chief Accounting Officer) | Option Ex | 33,332 | 72.11 | 2,403,570 |
2016-07-12 | Pascoe Kevin Carlton (EVP - Investments) | Option Ex | 13,333 | 72.11 | 961,442 |
2016-07-06 | Mccabe Robert A Jr (Director) | Option Ex | 20,000 | 72.11 | 1,442,200 |
2016-07-05 | Mendelsohn D. Eric (CEO and President) | Option Ex | 26,666 | 72.11 | 1,922,885 |
2016-07-01 | Pascoe Kevin Carlton (EVP - Investments) | Option Ex | 13,333 | 72.11 | 961,442 |
2016-07-01 | Jobe James R (Director) | Option Ex | 20,000 | 72.11 | 1,442,200 |
2016-06-30 | Webb Robert T (Director) | Option Ex | 20,000 | 72.11 | 1,442,200 |
2016-06-29 | Gaines Kristin Sallee (Chief Credit Officer) | Sale | 4,608 | 74.23 | 342,033 |
2016-06-28 | Gaines Kristin Sallee (Chief Credit Officer) | Sale | 4,044 | 73.71 | 298,067 |
2016-06-27 | Gaines Kristin Sallee (Chief Credit Officer) | Option Ex | 16,668 | 47.52 | 792,063 |
2016-06-13 | Mccabe Robert A Jr (Director) | Sale | 1,250 | 71.61 | 89,515 |
2016-05-10 | Pascoe Kevin Carlton (EVP - Investments) | Sale | 2,000 | 70.72 | 141,438 |
2016-05-05 | Mccabe Robert A Jr (Director) | Option Ex | 20,000 | 60.52 | 1,210,400 |
2016-04-18 | Hopkins Roger R (Chief Accounting Officer) | Option Ex | 116,666 | 62.56 | 7,298,624 |
2016-04-15 | Pascoe Kevin Carlton (EVP - Investments) | Option Ex | 10,000 | 64.49 | 644,900 |
2016-04-15 | Webb Robert T (Director) | Option Ex | 20,000 | 60.52 | 1,210,400 |
2016-04-14 | Gaines Kristin Sallee (Chief Credit Officer) | Option Ex | 33,334 | 56.01 | 1,866,870 |
2016-04-11 | Spaid John L (Exec. VP of Finance) | Option Ex | 13,333 | 63.63 | 848,378 |
2016-03-29 | Pascoe Kevin Carlton (EVP - Investments) | Option Ex | 43,333 | 61.05 | 2,645,349 |
2016-03-28 | Mendelsohn D. Eric (CEO and President) | Option Ex | 25,000 | 60.52 | 1,513,000 |
2016-03-28 | Hopkins Roger R (Chief Accounting Officer) | Sale | 10,000 | 65.45 | 654,500 |
2015-12-31 | Gaines Kristin Sallee (Chief Credit Officer) | Option Ex | 16,668 | 46.22 | 770,394 |
2015-12-11 | Mccabe Robert A Jr (Director) | Buy | 35 | 59.10 | 2,068 |
2015-11-27 | Mccabe Robert A Jr (Director) | Buy | 130 | 60.34 | 7,844 |
2015-11-17 | Mendelsohn D. Eric (CEO and President) | Buy | 1,000 | 56.12 | 56,120 |
2015-08-31 | Mccabe Robert A Jr (Director) | Buy | 310 | 56.21 | 17,425 |
2015-08-26 | Mendelsohn D. Eric (Interim CEO and President) | Buy | 750 | 55.38 | 41,538 |
2015-08-26 | Adams W Andrew (Director) | Buy | 2,000 | 55.50 | 111,000 |
2015-08-25 | Jobe James R (Director) | Buy | 100 | 56.68 | 5,668 |
2015-08-25 | Webb Robert T (Director) | Buy | 5,000 | 56.75 | 283,750 |
2015-08-24 | Mendelsohn D. Eric (Interim CEO and President) | Buy | 750 | 56.99 | 42,742 |
2015-08-13 | Pascoe Kevin Carlton (EVP - Investments) | Buy | 500 | 58.61 | 29,305 |
2015-08-13 | Gaines Kristin Sallee (Chief Credit Officer) | Buy | 2,000 | 58.38 | 116,760 |
2015-08-13 | Mendelsohn D. Eric (Interim CEO and President) | Buy | 1,500 | 58.80 | 88,200 |
2015-08-13 | Hopkins Roger R (Chief Accounting Officer) | Buy | 1,500 | 58.61 | 87,915 |
2015-08-13 | Jobe James R (Director) | Buy | 100 | 58.71 | 5,871 |
2015-06-09 | Mendelsohn D. Eric (EVP - Corporate Finance) | Buy | 500 | 63.80 | 31,900 |
2015-05-29 | Mccabe Robert A Jr (Director) | Buy | 265 | 66.99 | 17,752 |
2015-05-14 | Jobe James R (Director) | Buy | 200 | 66.37 | 13,274 |
2015-05-13 | Mendelsohn D. Eric (EVP - Corporate Finance) | Buy | 500 | 65.73 | 32,863 |
2015-05-12 | Mendelsohn D. Eric (EVP - Corporate Finance) | Buy | 1,000 | 65.79 | 65,794 |
2015-03-31 | Hutchens James Justin (CEO and President) | Sale | 5,950 | 70.26 | 418,035 |
2015-02-27 | Mccabe Robert A Jr (Director) | Buy | 398 | 71.17 | 28,327 |
2015-01-12 | Gaines Kristin Sallee (Chief Credit Officer) | Option Ex | 33,332 | 64.49 | 2,149,580 |
2015-01-09 | Mccabe Robert A Jr (Director) | Option Ex | 30,000 | 62.90 | 1,887,000 |
2015-01-09 | Webb Robert T (Director) | Option Ex | 30,000 | 62.90 | 1,887,000 |
2015-01-08 | Hutchens James Justin (CEO and President) | Option Ex | 200,000 | 62.37 | 12,474,000 |
2015-01-08 | Hopkins Roger R (Chief Accounting Officer) | Option Ex | 50,002 | 47.20 | 2,359,844 |
2015-01-08 | Jobe James R (Director) | Option Ex | 15,000 | 61.31 | 919,650 |
Insider trading activities including stock purchases, stock sales, and option exercises of NHI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of National Health Investors Inc (symbol NHI, CIK number 877860) see the Securities and Exchange Commission (SEC) website.